Editor's note: whither occupational health and safety?

par Bayer, R
Publié 2000

The debate over maternal-fetal HIV transmission prevention trials in Africa, Asia, and the Caribbean: racist exploitation or exploitation of racism?

par Bayer, R
Publié 1998

Science, justice, and breast implants.

par Bayer, R
Publié 1999

AIDS and the duty to treat: risk, responsibility, and health care workers.

par Bayer, R
Publié 1988

AIDS prevention and cultural sensitivity: are they compatible?

par Bayer, R
Publié 1994

Notifying workers at risk: the politics of the right-to-know.

par Bayer, R
Publié 1986

The ethics of blinded HIV surveillance testing.

par Bayer, R
Publié 1993

Discrimination, informed consent, and the HIV infected clinician.

par Bayer, R.
Publié 1997

Operating systems : an advanced course /

par Bayer, R.
Publié 1978.

Q fever as an occupational illness at the National Institutes of Health.

par Bayer, R A
Publié 1982

The ethics of screening for early intervention in HIV disease.

par Levine, C, Bayer, R
Publié 1989

Ethical challenges posed by clinical progress in AIDS.

par Bayer, R, Stryker, J
Publié 1997

AIDS and the limits of control: public health orders, quarantine, and recalcitrant behavior.

par Bayer, R, Fairchild-Carrino, A
Publié 1993

HIV prevention and the two faces of partner notification.

par Bayer, R, Toomey, K E
Publié 1992

The dual epidemics of tuberculosis and AIDS: ethical and policy issues in screening and treatment.

par Bayer, R, Dubler, N N, Landesman, S
Publié 1993

Toward justice in health care.

par Bayer, R, Callahan, D, Caplan, A L, Jennings, B
Publié 1988

Directly observed therapy and treatment completion for tuberculosis in the United States: is universal supervised therapy necessary?

par Bayer, R, Stayton, C, Desvarieux, M, Healton, C, Landesman, S, Tsai, W Y
Publié 1998

DETERMINATION OF CORN STALK FIBERS’ STRENGTH THROUGH MODELING OF THE MECHANICAL PROPERTIES OF ITS COMPOSITES

par Manuel Rodriguez, Alejandro Rodriguez, Jordi Bayer R., Fabiola Vilaseca, Jordi Girones, Pere Mutje
Publié 2010-11-01

Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington disea...

par Kordower, J H, Charles, V, Bayer, R, Bartus, R T, Putney, S, Walus, L R, Friden, P M
Publié 1994

Hepatitis B virus surface antigen binds to apolipoprotein H.

par Mehdi, H, Kaplan, M J, Anlar, F Y, Yang, X, Bayer, R, Sutherland, K, Peeples, M E
Publié 1994